ML-141

N/A

Report date: 2025/03/13 10:07:23
NME

Base Information

Drug NameML-141
Drug Alias NameML-141
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin modulatorsTubulin polymerisation promotersMitosis inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeridian Lab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeridian Lab
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A